Jump to content

Talk:Olaparib

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

Question

[edit]

Does it inhibit just PARP1 or other PARP enzymes ? Rod57 (talk) 11:43, 22 October 2009 (UTC)[reply]

Exaggerated coverage

[edit]

The Journal of the National Cancer Institute gave olaparib as an example of exaggerated coverage in the news media. Promoting Healthy Skepticism In The News: Helping Journalists Get It Right

Try to keep out some of the more hysterical claims. --Nbauman (talk) 01:56, 23 November 2009 (UTC)[reply]

FDA approved yesterday

[edit]

An FDA news release announces:

  • FDA approves Lynparza to treat advanced ovarian cancer
  • First LDT companion diagnostic test also approved to identify appropriate patients

Hope this is useful. --Hordaland (talk) 02:08, 20 December 2014 (UTC)[reply]

How many people have taken this?

[edit]

It would be helpful to get some statistical estimates of how many people have taken this medication. That would help me, as a consumer, evaluate its effectiveness and safety. I think it's a fairly rare medication, but I'm not sure. — Preceding unsigned comment added by Skysong263 (talkcontribs) 15:16, 8 May 2018 (UTC)[reply]

Dangling References

[edit]

Reference #6 (to: http://www.emea.europa.eu/pdfs/human/comp/opinion/51078707en.pdf ) referes to non-existent target.